| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1576 |
| Trial ID | NCT02640209 |
| Disease | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Terminated |
| Title | Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL) |
| Year | 2015 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC 18415, 823584 |
| Cohort 1 | |||||||||||
|
|||||||||||